關於 cookie 的說明

本網站使用瀏覽器紀錄 (Cookies) 來提供您最好的使用體驗,我們使用的 Cookie 也包括了第三方 Cookie。相關資訊請訪問我們的隱私權與 Cookie 政策。如果您選擇繼續瀏覽或關閉這個提示,便表示您已接受我們的網站使用條款。

Global Business NewsGlobal Business News

目前Global Business News文章數, 共 21625 篇 ,以下為 217 - 240 篇 訂閱此列表,掌握最新動態
M31 Announces the Launch of Advanced LPDDR Memory IP to Support HPC Applications

HSINCHU, June 19, 2024 /PRNewswire/ -- M31 Technology Corporation (M31), a global provider of silicon intellectual property (IP), announced the launch of the latest LPDDR memory IP solution to meet the growing demand in the high-performance computing (HPC) application market, even looking beyond the computing power to the artificial intelligence (AI) field, where there is also storage, rapid data retrieval, encryption, and massive data analysis. As a result, the booming development of AI from the cloud to the edge will drive significant business opportunities for memory IP. The M31's LPDDR4/4X, which has been designed and widely used, provides stable high performance and low power consumption characteristics, supports speeds up to 4,267Mbps, and provides self-training algorithms to help customers achieve optimal performance in various scenarios. It is suitable for applications requiring high-performance memory interfaces such as autonomous driving, mobile devices, and laptops. The LPDDR5 memory IP under development will further enhance the efficiency of HPC applications by providing higher data transfer rates and lower bit power consumption. In the future, M31 has also planned to develop LPDDR6 to fulfill more efficient and complex computing needs. M31's LPDDR5/5X/5T memory IP offers exceptional data transfer rates, ensuring optimal performance for HPC applications, including data centers, AI workloads, and advanced scientific computing. At the same time, the LPDDR5 design emphasizes power efficiency, reducing energy consumption by up to 30% compared to previous generations, making it suitable for large-scale computing environments where energy efficiency is critical. Data rates of up to 9600 Mbps facilitate faster processing speeds and more efficient data handling, which are essential for real-time analysis and intensive computing tasks. Utilizing advanced error correction technology ensures higher data integrity and reliability, which is crucial for maintaining accuracy in complex computing processes. The LPDDR memory module is designed to occupy minimal space, providing flexibility in design and integration, making it particularly suitable for compact and high-density computing environments. Additionally, M31's LPDDR memory IP solutions are specifically tailored for data center applications, enhancing processing capabilities and reducing operational costs, thereby improving energy efficiency. In the field of AI, they accelerate model training and inference speeds, which are critical for AI and machine learning tasks. Meanwhile, LPDDR memory IP also shows strong demand in the edge computing market, where its high performance and low power consumption features help manufacturers build smaller, lighter, and more powerful edge computing devices. In addition to LPDDR, M31 is actively researching and developing other advanced memory technologies such as Graphics Double Data Rate (GDDR) memory. GDDR memory is optimized for graphics applications, providing extremely high data transfer rates and excellent performance, making it suitable for gaming, virtual reality, and professional graphics workstations. Utilizing M31's silicon-proven memory IP helps to meet the increasing high-performance computing demands and satisfy the AI application market, accelerating customers' product development processes. As the pace of AI evolution accelerates, the role of IP in SoC chip design becomes increasingly important. As a professional IP supplier, M31 is committed to innovation and excellence, keeping pace with the developments in the semiconductor industry and continually driving technological advancements.

文章來源 : PR Newswire 美通社 發表時間 : 瀏覽次數 : 59 加入收藏 :
Growatt Showcases Extensive Product Portfolio and Receives EUPD Research Top PV Brand Awards at SNEC PV Expo 2024

BERLIN, June 19, 2024 /PRNewswire/ -- Growatt, a global leading provider of distributed energy solutions, successfully concluded its exhibition at the SNEC PV Expo, held from June 13th to 15th in Shanghai, China. The event highlighted Growatt's receipt of the Top Brand PV 2024 awards in the inverter and energy storage sectors from EUPD Research and showcased an extensive range of solutions for residential, commercial, off-grid, and various other solar applications. Growatt, a global leading provider of distributed energy solutions, successfully concluded its exhibition at the SNEC PV Expo, held from June 13th to 15th in Shanghai, China. The event highlighted Growatt’s receipt of the Top Brand PV 2024 awards in the inverter and energy storage sectors from EUPD Research and showcased an extensive range of solutions for residential, commercial, off-grid, and various other solar applications. Lisa Zhang, Vice President of Growatt, commented on their accolades, "As a global top four PV inverter supplier, we are deeply honored to receive these awards. They are a testament to our dedication and R&D efforts in energy technologies and our progress in empowering homes, businesses, and communities worldwide over the past decade. Beyond being a solar inverter company, we specialize in innovative energy solutions that help individuals and corporations generate, save, and manage their energy usage." Recognized as the world's largest residential inverter supplier for several consecutive years, Growatt presented its latest residential solutions catering to diverse application scenarios. A key highlight was the NEO Series Microinverters for smaller household PV systems. The new NEO 1200-2000M-X offers advanced functionalities such as redundancy, expandability, and smart communication methods. Additionally, the X2 generation inverter product line features a lower start voltage for extended daily operation and an increased maximum string current of 16A, accommodating PV panels with larger wafers. On the residential storage side, Growatt showcased the Battery-Ready series (MIN XH, MOD XH, and MID XH) inverters, with tailored versions for regional markets such as the US, including the MIN 3000-11400TL-XH-US models. These inverters allow users to start with a PV-only system to reduce initial investment and easily expand to a storage system later with their plug-and-play design. The manufacturer also offers the versatile SPH 10kW HU inverter, which supports up to six units in parallel for a total of 60kW, integrating a generator port and smart load control function to eliminate grid reliance during outages. With ambitions to expand into larger-scale solar system and build a broader distributed energy ecosystem, Growatt presented the WIT 50-100K Inverter and APX Commercial Battery, designed for large corporate and industrial users. The WIT 50-100K inverter features up to ten MPPTs, a 2.0 DC/AC ratio, and uninterruptible power supply (UPS)-grade grid/off-grid switching capability. Furthermore, the company's popular MAX Series PV inverter now includes the MAX 320-350KTL3-X model. This model ranges from 320kW to 350kW with six MPPTs, each of which can be connected to five strings with a maximum MPPT current of 80A. It is also equipped with an intelligent string breaker to enhance the safety of PV power stations. "Leveraging our extensive experience and cutting-edge technology in the industry, our solutions are now more comprehensive than ever, empowering both small-scale residential systems and large-scale commercial enterprises to harness and store solar power for optimal energy usage," Zhang concluded, "As we look to the future, we remain steadfast in our pursuit of innovative solutions that will drive the global transition to renewable energy and ensure a brighter, more sustainable world for generations to come." CONTACT: info@ginverter.com

文章來源 : PR Newswire 美通社 發表時間 : 瀏覽次數 : 78 加入收藏 :
Ping An Announces Brand Upgrade of "Ping An Family Doctor"

HONG KONG and SHANGHAI, June 19, 2024 /PRNewswire/ -- The "Ping An Family Doctor Brand Upgrade Conference" was held in Shanghai recently. Ping An Insurance (Group) Company of China, Ltd. (hereafter "Ping An" or the "Group", HKEX: 2318 / 82318; SSE: 601318) has upgraded its "Ping An Family Doctor" brand with a one-stop, proactive health management services system and a commitment to providing "proactive health management, chronic disease control, and full disease management" to users. Michael Guo, Group Co-CEO, said, "As a world-leading financial brand, Ping An never forgets its original aspiration and vision, remains customer-needs oriented and provides customers worry-free, time-saving, and money-saving healthcare services, to further promote the high quality, systemic and standardized development of 'Internet + Family Doctor', and support the national 'Healthy China' vision." During the conference, Prof. Chi Chunhua, Chairperson-designate, General Practice Branch of Chinese Medical Association said that, as China's population aging trend intensifies, the public's health needs are becoming more diversified and complex. To meet the growing health needs of the public, developing family doctor services and searching for a better service operation model has become an inevitable trend in the new era health system reform. "There is still a long way to go to achieve high-quality development of family doctor contract services. The entire society should work together, to continue explore the family doctor contract service model, and utilize advanced internet technology to optimize and improve service scope and streamline processes," she said. Building a one-stop, proactive health management services system Ping An Health, the flagship of the Ping An Group's healthcare and senior care ecosystem, focuses on delivering "family doctor" and "senior care concierges" services, and has evolved into a one-stop provider of professional, comprehensive, high-quality health and senior care management services. As of 2023, users with family doctor membership were close to 13 million, with more than 98% of users indicating 100% satisfaction with its medical consultation service. Ping An Health's upgraded "Ping An Family Doctor" introduces a comprehensive one-stop proactive health management services system. Customers are offered worry-free, time-saving, and money-saving one-stop family healthcare management services through the support of a dedicated family doctor. The one-stop proactive health management services system includes: 1) a team of professional family doctors holding dual certification from Peking University International Hospital and the World Organization of Family Doctors (WONCA); 2) a 5A standard service process guided by the General Practice Branch of the Chinese Medical Association and certified by the Royal Australian College of General Practitioners (RACGP); 3) proactive health management services tailored to the needs of sub-healthy individuals, patients with chronic diseases, and people with medical conditions; and 4) providing 12 scarce medical resources to those in need. "Ping An Family Doctor" also announced its commitment to providing "proactive health management, chronic disease control, and full disease management". The commitment translates into different actions for different patient groups. For sub-healthy individuals, "Ping An Family Doctor" develops high-quality health management plans through automated health records and instant interpretation of physical examination reports. This enables timely physical examination and early treatment interventions. For chronic disease patients, "Ping An Family Doctor" combines Internet of Things (IoT) real-time monitoring and high-risk warnings with a 21-day lifestyle management program to help relieve chronic disease symptoms. For individuals with medical conditions, "Ping An Family Doctor" offers comprehensive disease management, including: 24/7 immediate pre-hospitalization consultations, precise recommendations for renowned doctors and hospitals and appointment registration assistance, full-time nursing service and care during hospitalization to ensure efficient treatment, and personalized "recovery guides" and follow-up visits after hospitalization for a smooth recovery. Exploring new ways to "synergize healthcare and insurance" for family doctor services The enhancement of "Ping An Family Doctor" is supported by the use of leading medical technology. Ping An Health has developed five significant databases over the years: for diseases, prescriptive medicine, medical products, medical resources and personal healthcare. The company has developed the world's most comprehensive knowledge map in the medical field. It has constructed an innovative multimodal medical large language model (LLM) and 12 artificial intelligence (AI) business models on this foundation. The "Ping An Doctor's Assistant" workbench of Ping An Health is capable of autonomously updating files and matching health plans, thereby simplifying the process of health management process. Additionally, Ping An employs AI for materialize a 100% quality check of all services, such as online consultations, electronic medical records, and prescription quality control, in order to ensure the safety and compliance of "Ping An Family Doctor".  Ping An's "insurance + healthcare" business strategy has been particularly successful in recent years. Healthcare and insurance synergy is a novel approach that seamlessly integrates distinct medical and healthcare services with the financial businesses of the payors, such as insurance. For instance, the "Ping An Zhen Xiang RUN 2023 Health Services Plan" of Ping An Life Insurance and Ping An Health, which offers health management services, including health, chronic diseases, and medical care, as well as wealth management and risk protection requirements for customers. The number of Ping An Life insurance customers that also used Ping An's healthcare services surpassed 20 million in 2023, with a service satisfaction rate of 99% and double-digit year-on-year growth. Looking forward, Ping An Health will further consolidate its family doctor service system, which serves as its primary business segment, and will focus on providing exceptional proactive health management solutions that are tailored to the growing medical and health needs of the general public. Meanwhile, Ping An Health will make substantial investments in the health and senior care ecosystem and continue to develop a distinctive development trajectory of the Chinese "managed care model." Additionally, the Company will strengthen its partnerships with financial and corporate clients for ensure the enterprise's rapid and stable expansion. – End – About Ping An Group Ping An Insurance (Group) Company of China, Ltd. (HKEx:2318 / 82318; SSE:601318) is one of the largest financial services companies in the world. It strives to become a world-leading provider of integrated finance, health and senior care services, Under the technology-driven "integrated finance + health and senior care" strategy, the Group provides professional "financial advisory, family doctor, and senior care concierge" services to its 234 million retail customers. Ping An advances intelligent digital transformation and employs technologies to improve financial businesses' quality and efficiency and enhance risk management. The Group is listed on the stock exchanges in Hong Kong and Shanghai. As of the end of 2023, Ping An had RMB11,583,417 million in total assets. The Group ranked 29th in the Forbes Global 2000 list in 2024 and 33rd in the Fortune Global 500 list in 2023. For more information, please visit www.group.pingan.com and follow us on LinkedIn - PING AN. About Ping An Health Ping An Healthcare and Technology Company Limited (stock short name: PA GOODDOCTOR, 01833.HK) is a flagship of Ping An Group's health and senior care ecosystem. As a one-stop health and senior care solution provider, the company provides professional, comprehensive, high-quality services to users. The Company is listed on the Main Board of HKEX (Hong Kong Exchanges and Clearing Limited) and is included in Hang Seng TECH Index. Ping An Health has received "A" from MSCI ESG rating for three consecutive years. In 2023, Ping An Health served more than 26 million paying users from insurance and financial institutions, and 5 million paying users from more than 1,500 business corporate clients.

文章來源 : PR Newswire 美通社 發表時間 : 瀏覽次數 : 58 加入收藏 :
Diabetes Researchers in China Demonstrate Early Insulin Therapy Significant Benefits Cardiovascular Health

BEIJING, June 19, 2024 /PRNewswire/ -- Recently, Professor Jianping Weng of the University of Science and Technology of China (USTC) and President of Anhui Medical University and his team of researchers from USTC, Southern Medical University and Peking University published the results of their latest research on the effects of early insulin therapy on cardiovascular health in adults with Type 2 Diabetes Mellitus (T2DM) in the journal Signal Transduction and Targeted Therapy. This study is the first in the world to demonstrate that early insulin therapy is associated with a significant reduction in the incidence of cardiovascular events in newly diagnosed patients with T2DM. This research signifies a breakthrough in the field of diabetes treatment, compelling us to rethink the diabetes treatment model. Diabetes has remained a serious global public health issue for over a century, with its burden only growing as populations shift to more urban, sedentary ways of living.  The heightened blood glucose levels of a person with diabetes can damage their cardiovascular systems, placing them at increased risk of cardiovascular events, which is why cardiovascular disease is one of the leading causes of mortality among people with diabetes. As such, effective blood glucose control, which has always been the main goal of diabetes therapy, is important to reduce the risk of cardiovascular events. Professor Weng and his led observed a total of 5,424 patients with type 2 diabetes over a period of 24 years. The results showed that, compared with patients who did not receive early insulin therapy, those who did saw a 31% reduced incidence of stroke and 28% reduction in hospitalization for heart failure, though it found no significant difference in the risk of coronary heart disease. This discovery stands to change the way doctors and patients approach therapy options for new diagnoses of TD2M, as the significant cardiovascular benefits may lead more favoring early insulin adoption at a time when many first explore alternatives to insulin therapy.   Over two decades of research by Professor Weng supports early insulin therapy The traditional model for treating newly diagnosed T2DM is a conservative "step-by-step" method that typically begins with lifestyle changes such as diet and exercise, with physicians only recommending pharmaceutical intervention such as insulin once the disease has progressed and it is becoming clear that blood glucose levels are going uncontrolled. This can be a problematic approach, as this often means that patients go months, even years, with high blood glucose levels causing lasting internal damage and increasing risk of complications. After years of clinical experience struggling with this contradiction, in 2000 Chinese endocrinologists Jianping Weng and Linong Ji began formally exploring the effects of early insulin therapy on patient outcomes. Initial results proved promising, as early insulin therapy demonstrated an improvement in pancreatic islet secretion and reduced complications from diabetes. This study proved that, with the right therapy, T2DM could be reversed and thus became an important basis for the formulation of diabetes guidelines in many countries. In 2001, Weng and Ji also coincidentally discovered that insulin intensification in type 2 diabetes can delay the progressive failure of beta cells. Subsequent observational studies by Weng's team showed that short-term intensive insulin treatment in patients with newly diagnosed T2DM and people with severe hyperglycemia could induce long-term improvements in blood glucose control and beta cell function. These research results were published in Diabetes Care in 2004. Weng's team then conducted a multi-center randomized controlled study demonstrating that early insulin therapy was superior to oral blood glucose drugs in restoring and maintaining beta cell function and lowering overall blood glucose levels. These results were published in The Lancet in 2008, marking the first time such a 'honeymoon period' induced by early insulin therapy was mentioned in the prestigious publication. Weng and his team was the first to prove that pancreatic islet function in T2M is reversible, and successfully verified the "beta cell rest" theory in T2DM therapy. Professor Weng said, "Clinical results show that early insulin therapy can not only successfully control blood glucose and reduce overall blood sugar levels, but also restore beta cell function and reduce insulin resistance. This new treatment method encourages us to rethink how we approach diabetes treatment and significantly impact how we formulate treatment strategies." Initially proposed to answer the question as to when physicians should recommend starting insulin treatment, Weng's research is still often cited by endocrinologists around the world, with Dutch journal Elsevier rating him as one of China's most cited scholars for three consecutive years from 2020 to 2022. The results of his studies on early insulin therapy have been cited by more than 60 treatment guidelines around the world, including "Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy" which was jointly published by American Diabetes Association and the European Diabetes Association in 2009 and the 2013, 2017, and 2020 editions of China's Type 2 Diabetes Prevention and Treatment Guidelines. The paper has also been included or cited in many endocrinology textbooks. The cardiovascular benefits of early insulin therapy in people newly diagnosed with T2DM For most people with T2DM, insulin therapy is eventually necessary in order to control blood glucose levels. Previous studies demonstrated that early insulin therapy can help control blood control and restore beta cell function in patients with type 2 diabetes, but how this therapy affected cardiovascular health has remained a mystery. This recently published study into how early insulin therapy can reduce the incidence of cardiovascular events such as stroke, heart failure, and coronary heart disease in newly diagnosed patients with T2DM can be seen as a follow-up to Weng's 2008 article in The Lancet in that it demonstrates even further benefits from early insulin therapy on long-term patient outcomes. This new evidence promoting early insulin therapy could change the future of insulin therapy and provide key evidence for setting treatment guidelines. Speaking on the results of this study, Professor Ji said, "Type 2 diabetes is an important risk factor for cardiovascular disease morbidity and mortality. Clinical guidelines also emphasize that, when selecting a potential therapy, in addition to lowering blood glucose levels, it is also very important to reduce the risk of cardiovascular events. Different patients should adopt individualized target management, blood sugar monitoring and corresponding treatment plans. We hope that this study will provide a basis for exploring more effective ways to reduce the risk of cardiovascular disease in patients with diabetes." Early insulin therapy may bring cardiovascular benefits by improving blood glucose control in patients with type 2 diabetes, producing metabolic memory, reducing glucotoxicity, promoting the dedifferentiation of beta cells, improving beta cell function, and reducing the production of pro-inflammatory cytokines. As research continues and treatment methods improve, studies such as this challenge us to rethink current diabetes treatment models and correct misconceptions about the use of insulin. With better treatment, newly diagnosed people with diabetes will be able to reduce complications and the long-term impact of their condition, helping them live longer and healthier lives.  

文章來源 : PR Newswire 美通社 發表時間 : 瀏覽次數 : 58 加入收藏 :
Bybit Launches Copy Trading Pro for Collective and Synchronized Investing, Allowing Investors to Earn Passive Income with More Consistent Returns

DUBAI, UAE, June 19, 2024 /PRNewswire/ -- Bybit, one of the world's top three crypto exchanges by volume, is thrilled to announce the launch of Copy Trading Pro, an advanced platform that connects investors with meticulously vetted expert traders known as Pro Masters. Bybit Launches Copy Trading Pro for Collective and Synchronized Investing, Allowing Investors to Earn Passive Income with More Consistent Returns These Pro Masters have a proven track record and employ diverse investment strategies, including Spot and Derivatives trading, to maximize potential returns. Bybit Copy Trading Pro empowers investors to mirror the strategies of Pro Masters, aligning their investment goals with those of experienced traders to ensure a tailored investment approach. Key Benefits of Bybit Copy Trading Pro: For Pro Masters: Diversified Strategies: Pro Masters can trade across Spot and Derivatives markets, allowing them to diversify their strategies for enhanced flexibility and potential returns. Uninterrupted Execution: Investors' funds are locked in for 180 days, with redemption available every 7 days. Pro Masters can execute their strategies without concerns over sudden withdrawals, thus focusing on long-term profitability. Higher Profit Share: Pro Masters can earn up to 30% of the profits generated, providing them with a strong incentive to perform at their best. For Investors: Curated Expertise: Investors can confidently invest with meticulously vetted Pro Masters who meet high-performance standards, ensuring a safe investment environment. Seamless Alignment: Investments mirror Pro Master's trades, eliminating slippages, position gaps and missed opportunities. Stability and Trust: The platform incorporates safeguards such as 10x leverage limits and risk management tools, providing a stable and protected investment experience. "Bybit continues to push the boundaries of trading innovation with the introduction of Copy Trading Pro, empowering our users to make informed investment decisions and achieve their financial goals. With Copy Trading Pro, we are revolutionizing the way traders and investors participate in the crypto market, creating a safer and more mutually beneficial environment for both sides." said Joan Han, Sales and Marketing Director of Bybit. #Bybit / #TheCryptoArk About Bybit Bybit is one of the world's top three cryptocurrency exchanges by volume with 30 million users. Established in 2018. It offers a professional platform where crypto investors and traders can find an ultra-fast matching engine, 24/7 customer service, and multilingual community support. Bybit is a proud partner of Formula One's reigning Constructors' and Drivers' champions: the Oracle Red Bull Racing team. For more details about Bybit, please visit Bybit Press.For media inquiries, please contact: media@bybit.com For more information, please visit: https://www.bybit.com For updates, please follow: Bybit's Communities and Social Media Discord | Facebook | Instagram | LinkedIn | Reddit | Telegram | TikTok | X | Youtube

文章來源 : PR Newswire 美通社 發表時間 : 瀏覽次數 : 49 加入收藏 :
Sojern Now Available on Oracle Cloud Marketplace

Enhance real-time guest engagement and streamline marketing efforts using Sojern's Guest Experience Solutions with Oracle Hospitality Integration Platform SAN FRANCISCO, June 19, 2024 /PRNewswire/ -- Sojern, a leading digital marketing platform built for travel and a member of Oracle PartnerNetwork (OPN), today announced its suite of Guest Experience Solutions is available on Oracle Cloud Marketplace and can be deployed on Oracle Cloud Infrastructure (OCI) and integrated with OPERA Cloud via the Oracle Hospitality Integration Platform (OHIP). Oracle Cloud Marketplace is a centralized repository of enterprise applications offered by Oracle and Oracle partners. Logo, no tagline The Sojern Guest Experience Solutions enables hotel marketers to answer questions, resolve guest issues, and upsell services throughout the entire customer journey. Oracle Cloud Marketplace is a one-stop shop for Oracle customers seeking trusted business applications and services offering unique solutions, including ones that extend Oracle Fusion Cloud Applications. OCI is a deep and broad platform of cloud infrastructure services that enables customers to build and run a wide range of applications in a scalable, secure, highly available, and high-performance environment. From application development and business analytics to data management, integration, security, AI, and infrastructure services including Kubernetes and VMware, OCI delivers comprehensive security, performance, and cost savings. In addition, with multicloud, hybrid cloud, public cloud, and dedicated cloud options, OCI's distributed cloud offers customers the benefits of cloud with greater control over data residency, locality, and authority, even across multiple clouds. As a result, customers can bring enterprise workloads to the cloud quickly and efficiently while meeting the strictest regulatory compliance requirements. "Joining Oracle Cloud Marketplace marks a significant milestone for Sojern's hospitality customers. This two-way interface enhances real-time guest engagement, with a suite of tools designed to enhance the guest experience and operational efficiency within OHIP. Sojern's Reputation Manager empowers hoteliers to efficiently gather and manage feedback using generative AI for automated responses. Hospitality customers will also have access to advanced text and email marketing, along with auto reconciliation, simplifying marketing, performance, and measurement," said Noreen Henry, Chief Revenue Officer, Sojern. "Sojern's participation in Oracle Cloud Marketplace further strengthens our commitment to the Oracle community and enables customers to easily reap the benefits of Sojern's Guest Experience Solutions. We look forward to leveraging the power of the OCI to help us achieve our business goals."  For more information about Sojern's Guest Experience Solutions, click here. About Sojern Sojern is a leading travel marketing platform designed to boost growth and profitability for the travel industry. The Sojern Travel Marketing Platform is a set of easy-to-use software and services that delivers unrivaled traveler insight, intelligent audiences, multichannel activation and optimization, and a connected guest experience—all in one place. More than 10,000 travel marketers rely on our platform annually to find, attract, convert and engage travelers. Founded in 2007, Sojern is headquartered in San Francisco, California with teams in the Americas, Europe, Middle East and Africa, and Asia Pacific. About Oracle PartnerNetwork Oracle PartnerNetwork (OPN) is Oracle's partner program designed to enable partners to accelerate the transition to cloud and drive superior customer business outcomes. The OPN program allows partners to engage with Oracle through track(s) aligned to how they go to market: Cloud Build for partners that provide products or services built on or integrated with Oracle Cloud; Cloud Sell for partners that resell Oracle Cloud technology; Cloud Service for partners that implement, deploy and manage Oracle Cloud Services; Industry Healthcare for partners that provide commercially available products and/or services built with Oracle Cloud and Oracle Health technologies; and License & Hardware for partners that build, service or sell Oracle software licenses or hardware products. Customers can expedite their business objectives with OPN partners who have achieved Expertise in a product family or cloud service. To learn more visit: https://www.oracle.com/partnernetwork  Trademark Oracle, Java, MySQL and NetSuite are registered trademarks of Oracle Corporation. NetSuite was the first cloud company—ushering in the new era of cloud computing.

文章來源 : PR Newswire 美通社 發表時間 : 瀏覽次數 : 59 加入收藏 :
首 頁 我的收藏 搜 尋 新聞發佈